| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |